Furthermore, the activity of silent information regulator 1 (SIRT1) was increased, indicating that NMN treatment-activated SIRT1 may represent a new treatment strategy for PD (Zou et al., 2016). This evidence concerns the gene SIRT1 and Parkinson disease.